Beckman Coulter Selling $600M Worth of Senior Notes
 
Beckman Coulter this week said that it is offering $600 million worth of 2.5 percent senior convertible notes due 2036.
 
The offering, which includes a $75 million over-allotment option that has already been exercised, will net Beckman proceeds of $586 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.